KRAS and lung adenocarcinoma: The Hsp 90 inhibitor 17-DMAG can block IKK function and have better efficacy against KRASG12D-mutant lung adenocarcinoma, opening up a new way to prevent/treat KRAS-mutant LUAD [42].